A Multicentre Single Arm Phase II Trial Assessing the Efficacy of Immunotherapy, Chemotherapy and Stereotactic Radiotherapy to Metastases Followed by Definitive Surgery or Radiotherapy to the Primary Tumor, in Patients With Synchronous Oligo-metastatic Non-small Cell Lung Cancer. CHESS
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: EUROPEAN THORACIC ONCOLOGY PLATFORM
- Phase: II
- Execution start: 20/11/2019
- End of execution: 30/09/2022
- IP: JAVIER VALDIVIA BAUTISTA